• Latest Posts

“We are Pioneering Cell Therapy to Cure NASH and Fibrotic Disease”

UniQure takes an axe to its Pipeline and Workforce in new R&D Strategy

RNAi Therapy is Back: Sanofi is firmly on board to treat Hemophilia

Gene Therapy for severe Hemophilia has new Phase I/II Results

Rare Disease Biopharma can now sell Hemophilia treatment across whole of EU

ADVERTISEMENT

Global Hemophilia AID project achieves first milestone with donations from Swedish Biotech

Key-partnership for the most well-funded Biotech in Berlin

Apitope relocates to Wales after €12M series B financing round

Apitope’s peptide to take on Haemophilia A

Bayer Healthcare invests €94 Million in its Hemophilia pipeline

Sobi gets a long-lasting grip on a rare type of Hemophilia

ADVERTISEMENT